118 related articles for article (PubMed ID: 3352536)
1. Clinical and pathological evolution of alpha chain disease to immunoblastic lymphoma and response to COMP chemotherapy.
Rogers P; Hill I; Sinclair-Smith C; Bowie M
Med Pediatr Oncol; 1988; 16(2):128-31. PubMed ID: 3352536
[TBL] [Abstract][Full Text] [Related]
2. Primary small-intestinal lymphomas in Taiwan: immunoproliferative small-intestinal disease and nonimmunoproliferative small-intestinal disease.
Shih LY; Liaw SJ; Dunn P; Kuo TT
J Clin Oncol; 1994 Jul; 12(7):1375-82. PubMed ID: 8021727
[TBL] [Abstract][Full Text] [Related]
3. Immunoproliferative small intestinal disease in South India: a clinical and immunomorphological study.
Nair S; Mathan M; Ramakrishna BS; Mathan VI
J Gastroenterol Hepatol; 1998 Dec; 13(12):1207-11. PubMed ID: 9918427
[TBL] [Abstract][Full Text] [Related]
4. [Non-Hodgkin's lymphoma. Results of a therapeutic protocol].
Verdeguer A; Castel V; Mínguez JR; Ferris J
An Esp Pediatr; 1988 Oct; 29 Suppl 34():130-2. PubMed ID: 3214020
[No Abstract] [Full Text] [Related]
5. 'Real Life' experience in a 'difficult to treat' patient population of non-Hodgkin lymphomas using the R-COMP regimen.
Annibali O; Chiodi F; Cenfra N; Sarlo C; Mega S; Cavallari I; Rago A; Tomassini S; Mecarocci S; Cimino G; Avvisati G
Leuk Lymphoma; 2016 Dec; 57(12):2919-2922. PubMed ID: 27063923
[No Abstract] [Full Text] [Related]
6. Malabsorption associated with a high-grade-malignant non-Hodgkin's lymphoma, alpha-heavy-chain disease and immunoproliferative small intestinal disease.
Hubmann R; Kaiser W; Radaszkiewicz T; Fridrik M; Zazgornik I
Z Gastroenterol; 1995 Apr; 33(4):209-13. PubMed ID: 7793120
[TBL] [Abstract][Full Text] [Related]
7. Non-Hodgkin's lymphomas in Turkey: eighteen years' experience at the Hacettepe University.
Barista I; Tekuzman G; Firat D; Baltali E; Kansu E; Kars A; Ozisik Y; Ruacan S; Uzunalimoğlu B; Karaağaoğlu E
Jpn J Cancer Res; 1994 Dec; 85(12):1200-7. PubMed ID: 7531679
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy of Mediterranean abdominal lymphoma. Retrospective comparison of chemotherapy protocols in Iranian patients.
Salimi M; Spinelli JJ
Am J Clin Oncol; 1996 Feb; 19(1):18-22. PubMed ID: 8554029
[TBL] [Abstract][Full Text] [Related]
9. [Results of the treatment of 46 non-Hodgkin's lymphomas in children].
Zubeldia Sánchez J; Bezanilla Regato JL; Navajas Gutiérrez A; Burgos J; Moya Calderón E
An Esp Pediatr; 1988 Oct; 29 Suppl 34():133-7. PubMed ID: 3214021
[No Abstract] [Full Text] [Related]
10. Advances in chemotherapy for large cell lymphoma.
Coleman M; Gerstein G; Topilow A; Lebowicz J; Berhardt B; Chiarieri D; Silver RT; Pasmantier MW
Semin Hematol; 1987 Apr; 24(2 Suppl 1):8-20. PubMed ID: 2438781
[TBL] [Abstract][Full Text] [Related]
11. The Deauville criteria cannot differentiate between responding and non-responding non-Hodgkin lymphoma patients.
Adams HJA; Kwee TC
Ann Hematol; 2018 Apr; 97(4):719-720. PubMed ID: 29222579
[No Abstract] [Full Text] [Related]
12. CHOP versus m-BACOD in non-Hodgkin's lymphoma.
Hryniuk W
N Engl J Med; 1993 Feb; 328(8):581. PubMed ID: 7678920
[No Abstract] [Full Text] [Related]
13. [Intestinal non-Hodgkin lymphoma: "immunoproliferative small intestinal disease"].
Mrabti H; Raiss G; Raissouni S; Tazi el M; Inghaouen H; El Ghissassi I; Errihani H
Presse Med; 2011 Nov; 40(11):995-1000. PubMed ID: 21458210
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological features and management of immunoproliferative small intestinal disease and primary small intestinal lymphoma in Pakistan.
Malik IA; Shamsi Z; Shafquat A; Aziz Z; Shaikh H; Jafri W; Khan MA; Khan AH
Med Pediatr Oncol; 1995 Nov; 25(5):400-6. PubMed ID: 7674998
[TBL] [Abstract][Full Text] [Related]
15. Clinical investigations in aggressive non-Hodgkin lymphoma.
Jonathan F
Clin Adv Hematol Oncol; 2008 Sep; 6(9):7-8. PubMed ID: 18998259
[No Abstract] [Full Text] [Related]
16. Five-year results of the treatment of 23 patients with immunoproliferative small intestinal disease: a Turkish experience.
Akbulut H; Soykan I; Yakaryilmaz F; Icii F; Aksoy F; Haznedaroglu S; Yildirim S
Cancer; 1997 Jul; 80(1):8-14. PubMed ID: 9210703
[TBL] [Abstract][Full Text] [Related]
17. Should we suppress the antigenic stimulus in IPSID for lifelong?
Celik AF; Pamuk GE; Pamuk ON; Uzunismail H; Oktay E; Doğusoy G
Am J Gastroenterol; 2000 Nov; 95(11):3318-20. PubMed ID: 11095373
[No Abstract] [Full Text] [Related]
18. Primary non-Hodgkin,s lymphoma of the uterine cervix.
Hanprasertpong J; Hanprasertpong T; Thammavichit T; Kongkabpan D; Tungsinmunkong K; Chandeying N
Asian Pac J Cancer Prev; 2008; 9(2):363-6. PubMed ID: 18712992
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of patients with intermediate or high-grade non-Hodgkin lymphoma treated with a combination of cyclophosphamide, epirubicin, vincristine, and prednisone.
Rossini F; Terruzzi E; Perego D; Miccolis I; Rivolta F; Manca E; Pogliani EM
Cancer; 2004 Jan; 100(2):350-5. PubMed ID: 14716771
[TBL] [Abstract][Full Text] [Related]
20. Primary non-Hodgkin's lymphoma of liver with humoral hypercalcaemia.
Santhosh-Kumar CR; Ajarim DS; Shipkey FD
Postgrad Med J; 1990 Aug; 66(778):679-81. PubMed ID: 1699217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
